Psoriatic Arthritis
From the Journals
Smoking linked to increased psoriasis risk
South Korean study shows “positive correlation between the amount and/or duration of smoking and the occurrence of psoriasis.”
From the Journals
Ultrasound’s value for arthralgia may be to rule out IA
Ultrasound’s ability to predict the development of inflammatory arthritis was low.
News from the FDA/CDC
Adjuvant-boosted shingles vaccine earns FDA panel’s unanimous nod
The recombinant herpes zoster vaccine delivered 91% efficacy in patients aged 70 years and older.
Guidelines
New recommendations tout biosimilars for rheumatologic diseases
An international multidisciplinary task force came up with five overarching principles for the use of biosimilars and eight specific...
News
FDA approves second adalimumab biosimilar for multiple conditions
The biosimilar, called Cyltezo (adalimumab-adbm), is approved for all the same indications as Humira.
Latest News
Noninvasive NASH test could help monitor hepatotoxicity in patients on methotrexate
A noninvasive test for nonalcoholic steatohepatitis (NASH) and hepatic fibrosis can help monitor for hepatic fibrosis and could reduce the number...
From the Journals
Musculoskeletal ultrasound training now offered in nearly all U.S. rheumatology fellowships
Rheumatology fellowship programs offering musculoskeletal ultrasound training grew from 60% in a 2013 survey to 94% in 2017.
From the Journals
Study shows more changes, less stopping of PsA systemic drugs
Between 2004 and 2015, about 43% of PsA patients were treated with a biologic agent, results from a large study of national claims data showed.
Commentary
Psoriasis, psoriatic arthritis research makes headway at GRAPPA meeting
The meeting included sessions on juvenile psoriatic arthritis (PsA), the microbiome in psoriasis and PsA, and setting up longitudinal cohort...
From the Journals
Study finds secukinumab effective for moderate to severe scalp psoriasis
The results of a phase 3b study of secukinumab support its use as a treatment for scalp psoriasis.
News
FDA committee recommends approval of tofacitinib for PsA
The FDA Arthritis Advisory Committee voted 10-1 in favor of approval of tofacitinib for psoriatic arthritis.